Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04551339 · ClinicalTrials.gov registry record · NA
Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19
A NA study of Healthy and Aging, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 2,700
- Enrollment target
- 3
- Study locations
NCT04551339: Completed NA study of Healthy and Aging, sponsored by Mayo Clinic.
NCT04551339 is a NA study of Healthy and Aging that has completed, run by Mayo Clinic. The registered enrollment target is 2,700 participants, above the 645-participant average among 1,090 other Healthy trials with a reported enrollment target (319% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04551339, a NA study of Healthy and Aging, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,700 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research study is to look at high dose zinc versus multivitamin micronutrient supplementation to support immune health in the setting of the COVID-19 pandemic.
Primary Outcome
Total number of subjects admitted to the hospital in relations to COVID-19 illness PCR or undergo seroconversion
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT PreserVision AREDS formulation soft gels or tablets
- DIETARY_SUPPLEMENT Multivitamin with 11mg of zinc
Study Locations (3)
Arizona
- Mayo Clinic in Scottsdale - Scottsdale
Florida
- Mayo Clinic in Jacksonville - Jacksonville
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,700 participants |
| Start Date | 2020-09-28 |
| Est. Completion | 2021-05-28 |
| Phase | NA |
What the finished NCT04551339 record still lists
NCT04551339 is an interventional study that assigns participants to a tested intervention. Its 2,700 participants enrollment target places it among the larger protocols in the corpus, above the 645-participant average among 1,090 other Healthy trials with a reported enrollment target (319% higher).
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which PreserVision AREDS formulation soft gels or tablets is the first listed.
NCT04551339 reports a single indexed study location in Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT04551339 about?
NCT04551339 is a clinical study titled "Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19". The purpose of this research study is to look at high dose zinc versus multivitamin micronutrient supplementation to support immune health in the setting of the COVID-19 pandemic.
What is the current status of trial NCT04551339?
This trial is currently completed. It is a NA study. The enrollment target is 2,700 participants. The study started on 2020-09-28. Estimated completion is 2021-05-28.
What conditions does trial NCT04551339 study?
This clinical trial studies the following conditions: Healthy, Aging, Health Care Worker Patient Transmission.
What interventions are being tested in trial NCT04551339?
The interventions under investigation include: PreserVision AREDS formulation soft gels or tablets (DIETARY_SUPPLEMENT), Multivitamin with 11mg of zinc (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04551339?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04551339 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04551339's enrollment target sits among peer trials
2,700 18th of 1090 higher than 1,073 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
- NCT06052267 · 2,700 participants · Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI